David Young

Insider Reports History

Entity
Individual
Location
8850 Stanford Boulevard, Suite 2500, Columbia, MD
Signature
/s/s David Young by Michael B. Kirwan, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Young:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 80.9K $138K $1.71 Jul 10, 2024 Direct
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 31K $53K $1.71 Apr 5, 2024 By Young-Plaisance Revocable Trust
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Restricted Stock Units 25.2K $43K $1.71 Jun 28, 2024 Direct
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 18.5K $31.7K $1.71 Apr 5, 2024 By CorLyst, LLC
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 10.8K $18.4K $1.71 Apr 5, 2024 By Family Entities

Insider Reports Filed by David Young

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Apr 5, 2024 8 -$1.93K 4 Aug 2, 2024 Pres. Research & Development, Director
PCSA Processa Pharmaceuticals, Inc. Feb 7, 2024 1 $51.5K 4 Feb 8, 2024 Pres. Research & Development, Director
PCSA Processa Pharmaceuticals, Inc. Feb 6, 2024 1 $50.5K 4 Feb 7, 2024 Pres. Research & Development, Director
PCSA Processa Pharmaceuticals, Inc. Jan 1, 2024 3 -$1.45K 4 Apr 12, 2024 Pres. Research & Development, Director
PCSA Processa Pharmaceuticals, Inc. Oct 12, 2023 1 $45K 4 Oct 12, 2023 Pres. Research & Development, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Oct 10, 2023 1 $34.1K 4 Oct 10, 2023 Pres. Research & Development, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Jun 12, 2023 1 $32K 4 Jun 12, 2023 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Apr 14, 2023 1 $11K 4 Apr 14, 2023 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Apr 11, 2023 3 $29K 4 Apr 13, 2023 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Feb 9, 2023 1 $15K 4 Feb 10, 2023 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Dec 31, 2022 2 $0 4 Jan 4, 2023 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Sep 30, 2022 1 $0 4 Oct 3, 2022 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Aug 16, 2022 1 $0 4 Aug 23, 2022 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Aug 5, 2022 2 -$8.02K 4 Aug 9, 2022 President & CEO, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Apr 1, 2022 1 $0 4 Apr 11, 2022 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Dec 31, 2021 1 $0 4/A Jan 6, 2022 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Nov 1, 2021 2 $0 4 Apr 4, 2022 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Sep 30, 2021 1 $0 4/A Jan 6, 2022 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Aug 5, 2021 1 $0 4 Aug 9, 2021 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Jul 8, 2021 3 $0 4 Jul 9, 2021 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Jun 23, 2021 1 $76.7K 4 Jun 23, 2021 Chief Executive Officer, Director, 10%+ Owner
PCSA Processa Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Chief Executive Officer, Director, 10%+ Owner